CRISPR/Cas9-based rat model development

Since 2013, we have been heavily investing in CRISPR/Cas9-based rat model development, and have designed a unique offer, combining our:

• Expertise in model design
• Rigorous quality controls for rat models

With the advantages of gene editing technologies, such as:

• Cost effectiveness
• Short development time

‍

Your benefits and guarantees:

• Robust design for physiological relevant rat models
• Reliable and reproducible performance in many rat strains, including, but not limited to:
• Inbred: Brown Norway, Fischer 344, Lewis, etc.
• Outbred: Wistar, Long-Evans, Spraque Dawley, etc.

• Freedom to operate thanks to our unique IP portfolio, including licenses from MIT and Merck KGaA
• Rigorous off-target assessment